A-DERMA Exomega Control Emollient Foaming Gel Anti-Scratching 200ml
This item is currently being restocked at our warehouse. Please subscribe to our availability alert system to be notified when it becomes available.
|
6 to 10 days delivery from $17.76 |
|
2 to 3 days delivery from $26.66 |
A-DERMA Exomega Control Emollient Foaming Gel Anti-Scratching 200ml is an emollient foaming gel that gently cleanses, soothes and protects dry skin of the face and body prone to atopic eczema for the whole family, from birth. The formula is biodegradable according to the OECD 301B standard, it also minimizes the risk of allergic reactions.
Tested under dermatological and pediatric control.
Syndet soap-free, fragrance-free.
physiological pH.
Vegan: no ingredient of animal origin.
Bottles: up to 100% recycled PET.
Made in France.
In the shower or bath, apply to damp skin, lather and rinse. Rinse in case of contact with eyes.
Aqua (Water), Disodium Cocamphodiacetate, PEG-7 Glyceryl Cocoate, Decyl Glucoside, Polysorbate 20, Sodium Chloride, Ceteareth-60, Myristyl Glycol, Hydrogenated Starch Hydrolystae, Peg-200 Hydrogenated Glyceryl Palmate, 10-Hydroxydecenoic Acid, Avena Sativa (Oat) Leaf/Stem Extract (Avena Sativa Leaf/Stem Extract), Benzoic Acid, Citric Acid, Glycerin, Glyceryl Laurate, Lactic Acid, Maltodextrin, Oenothera Biennis (Evening Primrose) Oil (Oenothera Biennis Oil), Tocopherol.
* Rhealba Oat from Organic Farming.
| EAN Code | 3282770143737 |
| Form | Gel |
| Presentation | Bottle |
| Contents | 200ml |
Discover the A-DERMA brand
Aderma is the first dermo-cosmetic brand with a plant active ingredient from natural origin, the Rhealba Oat, which, thanks to its perfect pureness and exceptional richness of soothing active principles, takes care and protects fragile and delicate skins.
All the products are formulated with a minimum of ingredients and guaranteed without essential oil, colorant, alcohol. When possible, without fragrance and paraben. It has allowed Aderma to get the trust of dermatologists throughout the world and the recognition of users for the treatment of atopic and irritated skins.
